Showing results (221-230 of 618) with videos related to
Sort By:
Pageof 62
Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.CA: a Cancer Journal for Clinicians|May 7, 2010
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaErwin G Van Meir, Costas G Hadjipanayis, Andrew D Norden, et al.Journal of Neuro-Oncology|January 4, 2012
Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomasRohit R Das, Elinor Artsy, Shelley Hurwitz, et al.Neuro-Oncology|May 4, 2024
Radioligand therapies in meningioma: Evidence and future directionsMaximilian J Mair, Emeline Tabouret, Derek R Johnson, et al.Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.The Oncologist|June 11, 2020
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical TrialJorg Dietrich, Laura Versmee, Jan Drappatz, et al.Neuro-Oncology|July 17, 2013
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2Brian M Alexander, Patrick Y Wen, Lorenzo Trippa, et al.Neuro-Oncology|April 28, 2020
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the ElderlyShervin Tabrizi, Lorenzo Trippa, Daniel Cagney, et al.Nature Communications|October 2, 2022
The design and evaluation of hybrid controlled trials that leverage external data and randomizationSteffen Ventz, Sean Khozin, Bill Louv, et al.Cancer Medicine|June 12, 2023
Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasisDavid Cella, Patrick Y Wen, Claire Ervin, et al.Pageof 62